Calorie restriction and matched weight loss from exercise: Independent and additive effects on glucoregulation and the incretin system in overweight women and men

Diabetes Care

Volumn 38, Issue 7, 2015, Pages 1253-1262

  Weiss, Edward P ^a,b   Albert, Stewart G ^c   Reeds, Dominic N ^b   Kress, Kathleen S ^a   Ezekiel, Uthayashanker R ^a   McDaniel, Jennifer L ^a   Patterson, Bruce W ^b   Klein, Samuel ^b   Villareal, Dennis T ^b,d  

^a SAINT LOUIS UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1; INCRETIN; C PEPTIDE; GLUCOSE; GLUCOSE BLOOD LEVEL; INSULIN;

ADULT; AEROBIC CAPACITY; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; BODY COMPOSITION; BODY WEIGHT; CALORIC INTAKE; CALORIC RESTRICTION; CONTROLLED STUDY; DIETARY INTAKE; ENERGY EXPENDITURE; EXERCISE; FEMALE; GLUCOSE TOLERANCE; HORMONE ACTION; HUMAN; INSULIN RELEASE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; POSTMENOPAUSE; POSTPRANDIAL STATE; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SEDENTARY LIFESTYLE; TREATMENT RESPONSE; WEIGHT LOSS PROGRAM; WEIGHT REDUCTION; ADAPTATION; CLINICAL TRIAL; ENERGY METABOLISM; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; KINESIOTHERAPY; LIFESTYLE; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; OVERWEIGHT; PHYSIOLOGY; PROCEDURES; SECRETION (PROCESS);

ADAPTATION, PHYSIOLOGICAL; AGED; BLOOD GLUCOSE; C-PEPTIDE; CALORIC RESTRICTION; ENERGY INTAKE; ENERGY METABOLISM; EXERCISE THERAPY; FEMALE; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE; GLUCOSE TOLERANCE TEST; HUMANS; INCRETINS; INSULIN; INSULIN RESISTANCE; LIFE STYLE; MALE; MIDDLE AGED; OVERWEIGHT; POSTPRANDIAL PERIOD; WEIGHT LOSS;

EID: 84958670773     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc14-2913     Document Type: Article

References (34)

1. Weiss EP, Racette SB, Villareal DT, et al, .; Washington University School of Medicine CALERIE Group. Improvements in glucose tolerance and insulin action induced by increasing energy expenditure or decreasing energy intake: a randomized controlled trial. Am J Clin Nutr 2006;84:1033-1042
2. Knowler WC, Barrett-Connor E, Fowler SE, et al, .; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403
3. Tuomilehto J, Lindström J, Eriksson JG, et al, .; Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-1350
4. Gulve EA, Spina RJ. Effect of 7-10 days of cycle ergometer exercise on skeletal muscle GLUT-4 protein content. J Appl Physiol (1985) 1995;79:1562-1566
5. O'Gorman DJ, Karlsson HK, McQuaid S, et al. Exercise training increases insulin-stimulated glucose disposal and GLUT4 (SLC2A4) protein content in patients with type 2 diabetes. Diabetologia 2006;49:2983-2992
6. Ross R, Dagnone D, Jones PJ, et al. Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial. Ann Intern Med 2000;133:92-103
7. Drucker DJ. The biology of incretin hormones. Cell Metab 2006;3:153-165
8. González N, Acitores A, Sancho V, Valverde I, Villanueva-Peñacarrillo ML. Effect of GLP-1 on glucose transport and its cell signalling in human myocytes. Regul Pept 2005;126:203-211
9. Perea A, Viñambres C, Clemente F, Villanueva-Peñacarrillo ML, Valverde I. GLP-1 (7-36) amide: effects on glucose transport and metabolism in rat adipose tissue. Horm Metab Res 1997;29:417-421
10. Institute of Medicine. Food and Nutrition Board: Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids (Macronutrients). Washington, DC, The National Academies Press, 2002
11. Sallis JF. Seven-day physical activity recall. Med Sci Sports Exerc 1997;29(Suppl. 6):89-103
12. Dalla Man C, Campioni M, Polonsky KS, et al. Two-hour seven-sample oral glucose tolerance test and meal protocol: minimal model assessment of β-cell responsivity and insulin sensitivity in nondiabetic individuals. Diabetes 2005;54:3265-3273
13. Stumvoll M, Mitrakou A, Pimenta W, et al. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 2000;23:295-301
14. Gordon BA, Fraser SF, Bird SR, Benson AC. Reproducibility of multiple repeated oral glucose tolerance tests. Diabetes Res Clin Pract 2011;94:e78-e82
15. Otten J, Ahrén B, Olsson T. Surrogate measures of insulin sensitivity vs the hyperinsulinaemic-euglycaemic clamp: a meta-analysis. Diabetologia 2014;57:1781-1788
16. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999;22:1462-1470
17. Breda E, Cavaghan MK, Toffolo G, Polonsky KS, Cobelli C. Oral glucose tolerance test minimal model indexes of β-cell function and insulin sensitivity. Diabetes 2001;50:150-158
18. Van Cauter E, Mestrez F, Sturis J, Polonsky KS. Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 1992;41:368-377
19. Polonsky KS, Given BD, Hirsch L, et al. Quantitative study of insulin secretion and clearance in normal and obese subjects. J Clin Invest 1988;81:435-441
20. American College of Sports Medicine. ACSM's Guidelines for Exercise Testing and Prescription. Baltimore, Williams & Wilkins, 2014
21. American Diabetes Association. Standards of medical care in diabetes-2014. Diabetes Care 2014;37(Suppl. 1):S14-S80
22. Adam TC, Jocken J, Westerterp-Plantenga MS. Decreased glucagon-like peptide 1 release after weight loss in overweight/obese subjects. Obes Res 2005;13:710-716
23. Adam TC, Lejeune MP, Westerterp-Plantenga MS. Nutrient-stimulated glucagon-like peptide 1 release after body-weight loss and weight maintenance in human subjects. Br J Nutr 2006;95:160-167
24. Verdich C, Toubro S, Buemann B, Lysgård Madsen J, Juul Holst J, Astrup A. The role of postprandial releases of insulin and incretin hormones in meal-induced satiety - effect of obesity and weight reduction. Int J Obes Relat Metab Disord 2001;25:1206-1214
25. Weiss EP, Royer NK, Fisher JS, Holloszy JO, Fontana L. Postprandial plasma incretin hormones in exercise-trained versus untrained subjects. Med Sci Sports Exerc 2014;46:1098-1103
26. Heden TD, Liu Y, Kearney ML, et al. Prior exercise and postprandial incretin responses in lean and obese individuals. Med Sci Sports Exerc 2013;45:1897-1905
27. Solomon TP, Haus JM, Kelly KR, Rocco M, Kashyap SR, Kirwan JP. Improved pancreatic β-cell function in type 2 diabetic patients after lifestyle-induced weight loss is related to glucose-dependent insulinotropic polypeptide. Diabetes Care 2010;33:1561-1566
28. Kelly KR, Brooks LM, Solomon TP, Kashyap SR, O'Leary VB, Kirwan JP. The glucose-dependent insulinotropic polypeptide and glucose-stimulated insulin response to exercise training and diet in obesity. Am J Physiol Endocrinol Metab 2009;296:E1269-E1274
29. Mentlein R, Gallwitz B, Schmidt WE. Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum. Eur J Biochem 1993;214:829-835
30. Kieffer TJ, McIntosh CH, Pederson RA. Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV. Endocrinology 1995;136:3585-3596
31. Laferrère B, Teixeira J, McGinty J, et al. Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinol Metab 2008;93:2479-2485
32. Hansen KB, Vilsbøll T, Bagger JI, Holst JJ, Knop FK. Reduced glucose tolerance and insulin resistance induced by steroid treatment, relative physical inactivity, and high-calorie diet impairs the incretin effect in healthy subjects. J Clin Endocrinol Metab 2010;95:3309-3317
33. Bose M, Teixeira J, Olivan B, et al. Weight loss and incretin responsiveness improve glucose control independently after gastric bypass surgery. J Diabetes 2010;2:47-55
34. Laferrère B, Heshka S, Wang K, et al. Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes. Diabetes Care 2007;30:1709-1716